Quality of life in ovarian cancer survivors

  • Vânia Gonçalves Faculty of Psychology and Educational Sciences, University of Coimbra

Resumo

Ovarian cancer survivors may experience Quality of Life (QOL) disruptions due to the aggressiveness of the illness and its treatment. The present manuscript intends to review the most recent knowledge regarding QOL in ovarian cancer survivors. Firstly, a brief overview about QOL, their importance and instruments used to assess it particularly in ovarian cancer survivors are presented. Then, main findings and developments achieved to date are discussed. Main conclusions from studies reviewed and future research needs are outlined. Available literature suggests that in general ovarian cancer survivors experience a good QOL; however, some deficits are more prevalent than in women without cancer. Although, these studies brought to light important QOL issues, more rigorous and larger studies are necessary to fully understand ovarian cancer survivors' QOL. Measuring QOL in ovarian cancer survivors in clinical settings is of utmost importance to identify those survivors at risk and provide adequate support that meets their needs. 

Referências

Aaronson, N.K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N.J., Filiberti, A., Flechtner, H., Fleishman, S.B., & Haes, J.C. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute,85(5), 365-376.
Bowling, A. (2001). Health-related quality of life: conceptual meaning, use and measurement. Buckingham: Open University Press.
Cella, D.F., Tulsky, D.S., Gray, G.(1993). The Functional assessment of Cancer Therapy (FACT) scale: development and validation of the general measure. Journal of Clinical Oncology, 11(3), 570-579.
Chase, D.M., & Wenzel L (2011). Health-related quality of life in ovarian cancer patients and its impact on clinical management. Expert Review of Pharmacoeconomics & Outcomes Research,11(4), 421-31.
Cull, A., Howat, S., Greimel, E., Waldenstrom, A.C., Arraras, J., Kudelka, A., Chauvenet, L. & Gould, A. (2001). EORTC Quality of Life Group [European Organization for Research and Treatment of Cancer]; Scottish Gynaecological Cancer Trials Group. Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report. European Journal of Cancer, 37(1), 47-53.
Ferrell, B., Smith, S.L., Cullinane, C.A., (2003). Psychological well-being and quality of life in ovarian cancer survivors. Cancer, 98(5), 1061−1071.
Gonçalves, V. (2010). Long-term quality of life in gynaecological cancer survivors. Current Opinion in Obstetrics and Gynaecology, 22(1), 30-35.
Gonçalves, V., Jayson, G & Tarrier, N. (2011). A longitudinal investigation of posttraumatic stress disorder in patients with ovarian cancer. Journal of Psychosomatic Research, 70(5),422-431.
Gonçalves, V., Jayson, G., Tarrier, N. (2008). A longitudinal investigation of psychological morbidity in patients with ovarian cancer. British Journal of Cancer, 99 (11),1794-1801.
Greimel, E., Bottomley, A., Cull, A., Waldenstrom, A.C., Arraras, J., Chauvenet, L., Holzner, B., Kuljanic, K., Lebrec, J.& D'haese, S.(2003). EORTC Quality of Life Group and the Quality of Life Unit. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. European Journal of Cancer, 39(10),1402-1408.
Greimel, E., Daghofer, F.& Petru, E.(2011). Prospective assessment of quality of life in long-term ovarian cancer survivors. International Journal of Cancer, 128(12), 3005-3011.
Hess, L.M., & Stehman, F.B.(2012). State of the science in ovarian cancer quality of life research: a systematic review. International Journal of Gynecological Cancer, 22(7),1273-1280.
Higginson, I. (2001). Using quality of life measures in the clinical setting. British Medical Journal, 322 (7297), 1297-300.
Hipkins, J., Whitworth, M., Tarrier, N. & Jayson, G. (2004). Social support, anxiety and depression after chemotherapy for ovarian cancer: a prospective study. British Journal of Health Psychology, 9 (Pt 4), 569-581.
Huang, L., Cronin, K.A. & Johnson, K.A.(2008). Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer? Cancer, 112, 2289Y2300.
Jacobsen, P.B., Davis, K., & Cella, D.(2002). Assessing quality of life in research and clinical practice. Oncology (Williston Park), 16(9 Suppl 10), 133-139.
Liavaag, A.H., Dørum, A., Fosså, S.D., Tropé, C,.& Dahl, A. A.(2007). Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones? Journal of Clinical Oncology, 25(15), 2049-2056.
Matulonis, U.A., Kornblith, A., Lee, H., Bryan, J., Gibson, C., Wells, C., Lee, J., Sullivan, L., & Penson, R. (2008). Long-term adjustment of early-stage ovarian cancer survivors. International Journal of Gynecological Cancer, 18(6),1183-1193.
Mirabeau-Beale, K.L., Kornblith, A.B., Penson, R.T., Lee, H., Goodman, A., Campos, S.M., Duska, L., Pereira, L., Bryan, J. & Matulonis, U.A. (2009). Comparison of the quality of life of early and advanced stage ovarian cancer survivors. Gynecologic Oncology, 114(2), 353-359.
Murphy, B.A., Ridner, S., Wells, N., & Dietrich, M. (2007). Quality of life research in head and neck cancer: a review of the current state of the science. Critical Reviews in Oncology/ Hematology, 62(3), 251-67.
Norton, T.R., Manne, S.L., Rubin, S., Carlson, J., Hernandez, E., Edelson, M.I., Rosenblum, N., Warshal, D. & Bergman, C. (2004). Prevalence and predictors of psychological distress among women with ovarian cancer. Journal of Clinical Oncology, 22(5), 919-926.
Penson, R.T., Wenzel, L.B., Vergote, I., & Cella, D.(2006). Quality of life considerations in gynecologic cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal of Gynaecology and Obstetrics, 95 Suppl 1, S247-57.
Siegel, R., Naishadham, D., & Jemal, A. (2012). Cancer statistics. CA: A Cancer Journal for Clinicians, 62 (5).
Stavraka, C., Ford, A., Ghaem-Maghami, S., Crook, T., Agarwal, R., Gabra, H., & Blagden, S.A.(2012). Study of symptoms described by ovarian cancer survivors. Gynecologic Oncology, 125(1), 59-64.
Stewart, D.E., Wong, F., Duff, S., Melancon, C.H., & Cheung, A.M. (2001). "What doesn't kill you makes you stronger": an ovarian cancer survivor survey. Gynecologic Oncology; 83(3), 537-542.
Teng, F.F., Kalloger, S.E., Brotto, L., & McAlpine, J.N.(2014). Determinants of quality of life in ovarian cancer survivors: a pilot study. Journal of Obstetrics and Gynaecology Canada, 36(8), 708-15.
Velikova, G., Stark, D., & Selby, P.(1999). Quality of life instruments in oncology. European Journal of Cancer, 35 (11), 1571-80.
Wenzel, L.B., Donnelly, J.P., Fowler, J.M., Habbal, R., Taylor, T.H., Aziz, N., & Cella D. (2002). Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study. Psychooncology, 11(2), 142-153.
WHOQOL Group. (1993). Measuring Quality of Life: The development of the World Health Organization Quality of Life Instrument (WHOQOL). Geneva: WHO.
Publicado
2015-11-20
Secção
Educação e formação em saúde